MedDataX Logo

Evaluation of Tetrix Cream as a Protective Barrier Against Injurious Materials

NCT ID: NCT00643630

Last Updated: 2008-05-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-10-31

Study Completion Date

2007-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine if Tetrix Cream,, when applied to the skin, acts as a barrier to prevent injury to the skin

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Tetrix crea skin barrier antigen reaction prevention The efficacy of Tetrix Cream to prevent an antigen reaction on the skin.

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Twice daily topical application

Group Type EXPERIMENTAL

Tetrix

Intervention Type DEVICE

Twice daily topical application

2

Twice daily topical application

Group Type PLACEBO_COMPARATOR

Tetrix

Intervention Type DEVICE

Twice daily topical application

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tetrix

Twice daily topical application

Intervention Type DEVICE

Tetrix

Twice daily topical application

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Normal subjects who are sensitized to nickel, neomycin, or fragrance mix.

Exclusion Criteria

* Under 18 years of age.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Coria Laboratories, Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Coria Laboratories, Ltd.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joseph Fowler, MD

Role: PRINCIPAL_INVESTIGATOR

Dermatology Specialists

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dermatolgoy Specialists, LLC

Louisville, Kentucky, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

806 805 09 002

Identifier Type: -

Identifier Source: org_study_id